Sign in

CIK 0000812796 · Non-accelerated filer<br>Smaller reporting company

SOLIGENIX, INC.

Sign in to watch
Ticker
SNGX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
411505029
Phone
609-538-8200
Business address
29 EMMONS DRIVE, SUITE B-10, PRINCETON, NJ, 08540
Former names
SOLIGENIX, INC., DOR BIOPHARMA INC, ENDOREX CORP, IMMUNOTHERAPEUTICS INC
  1. 8-K Event Item 4 · Item 7
  2. 10QSB Other 10QSB
  3. 4 Insider Changes in Ownership
  4. 10QSB Other 10QSB
  5. S-3 Offering Registration Statement
  6. DEF 14A Proxy Proxy Statement
  7. PRE 14A Proxy Proxy Statement (Preliminary)
  8. 10KSB Other 10KSB
  9. 8-K Event Item 1
  10. SC 13D/A Stake Beneficial Ownership Report
  11. 4 Insider Changes in Ownership
  12. 4 Insider Changes in Ownership
  13. 4 Insider Changes in Ownership
  14. 4 Insider Changes in Ownership
  15. 424B3 Offering Prospectus
  16. S-3 Offering Registration Statement
  17. 10QSB Other 10QSB
  18. SC 13D/A Stake Beneficial Ownership Report
  19. S-3/A Offering Registration Statement
  20. 10QSB Other 10QSB

Page 68 of 72 · 1,429 filings